Breaking News Instant updates and real-time market news.

CVS

CVS Health

$62.34

-0.72 (-1.14%)

04:55
10/02/19
10/02
04:55
10/02/19
04:55

CVS Health management to meet with RBC Capital

Meetings to be held in Toronto on October 1-2 hosted by RBC Capital.

  • 02

    Oct

CVS CVS Health
$62.34

-0.72 (-1.14%)

08/09/19
MSCO
08/09/19
NO CHANGE
Target $74
MSCO
Overweight
CVS's Q2 gives window into possible power of the enterprise, says Morgan Stanley
Morgan Stanley analyst Ricky Goldwasser said CVS Health's Q2 results and conference call "provided a window to what the power of the enterprise could materialize into," citing improved retail comps, share gains and the company's Medicare Advantage strategies. The analyst, who thinks the company's opportunity to capture share in Medicare Advantage organically by cross-selling is underestimated by the market, keeps an Overweight rating and $74 price target on CVS shares.
08/27/19
COWN
08/27/19
NO CHANGE
Target $76
COWN
Outperform
CVS Health price target raised to $76 from $69 at Cowen
Cowen analyst Charles Ryhee raised his price target on CVS Health to $76 from $69 to reflect revised 2019 guidance. The analyst believes the 2019 guidance looks conservative and with faster synergy realization and improved 2020 selling season, the company's 2020 guidance looks achievable. Ryhee reiterated his Outperform rating on CVS Health shares.
09/11/19
DBAB
09/11/19
INITIATION
Target $91
DBAB
Buy
CVS Health initiated with a Buy at Deutsche Bank
Deutsche Bank analyst George Hill initiated CVS Health with a Buy rating and a Top Pick designation along with a price target of $91 as part of a broader research note on Healthcare Technology & Services. The analyst contends that the company is "well positioned to deliver on a vertical integration care delivery strategy", capturing market share and generating positive earnings surprises. Hill also sees the valuation of CVS shares as "highly compelling".
09/27/19
RBCM
09/27/19
INITIATION
Target $85
RBCM
Outperform
CVS Health assumed with an Outperform at RBC Capital
RBC Capital analyst Anton Hie assumed coverage of CVS Health with an Outperform rating and a price target of $59. The analyst believes that the company is "positioned to lead the transformation of healthcare delivery" using its "unique" vertically integrated assets and contends that investors underappreciate the opportunity for CVS Health amid near-term headwinds. Hie adds that the company can accelerate its earnings growth toward its long-term target in the "low double digits" by 2022, with integration synergies and "enterprise modernization" helping to deliver about $3.5B in additional operating income.

TODAY'S FREE FLY STORIES

$NYE

NYSE Market Internals

$0.00

(0.00%)

16:16
11/19/19
11/19
16:16
11/19/19
16:16
Technical Analysis
NYSE market internals summary »

Volume was average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SSKN

Strata Skin Sciences

$2.30

-0.3 (-11.54%)

16:15
11/19/19
11/19
16:15
11/19/19
16:15
Hot Stocks
Strata Skin Sciences regains compliance with Nasdaq listing rules »

STRATA Skin Sciences…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CTMX

CytomX Therapeutics

$5.17

-0.01 (-0.19%)

16:15
11/19/19
11/19
16:15
11/19/19
16:15
Initiation
CytomX Therapeutics initiated  »

CytomX Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ALNY

Alnylam

$98.02

5.32 (5.74%)

16:14
11/19/19
11/19
16:14
11/19/19
16:14
Initiation
Alnylam initiated  »

Oppenheimer starts…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

  • 07

    Dec

  • 04

    Feb

AKCA

Akcea Therapeutics

$19.06

0.31 (1.65%)

, IONS

Ionis Pharmaceuticals

$58.03

0.26 (0.45%)

16:13
11/19/19
11/19
16:13
11/19/19
16:13
Hot Stocks
Akcea Therapeutics announces closing of licensing agreement with Pfizer »

Akcea Therapeutics…

AKCA

Akcea Therapeutics

$19.06

0.31 (1.65%)

IONS

Ionis Pharmaceuticals

$58.03

0.26 (0.45%)

PFE

Pfizer

$37.64

0.43 (1.16%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

  • 21

    Nov

  • 22

    Nov

  • 07

    Dec

ENDP

Endo

$4.44

-0.02 (-0.45%)

16:11
11/19/19
11/19
16:11
11/19/19
16:11
Hot Stocks
Endo announces FDA accepted for review the original BLA for CCH »

Endo International…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CNNE

Cannae Holdings

$36.57

-0.27 (-0.73%)

16:10
11/19/19
11/19
16:10
11/19/19
16:10
Hot Stocks
Cannae Holdings names Richard Massey as new CEO »

Cannae Holding announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMRN

Amarin

$22.72

0.09 (0.40%)

16:10
11/19/19
11/19
16:10
11/19/19
16:10
Initiation
Amarin initiated  »

Amarin initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Dec

JNJ

Johnson & Johnson

$134.83

-0.01 (-0.01%)

16:10
11/19/19
11/19
16:10
11/19/19
16:10
Initiation
Johnson & Johnson initiated  »

Johnson & Johnson…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Nov

  • 07

    Dec

  • 21

    Jan

DAN

Dana

$16.81

0.105 (0.63%)

16:09
11/19/19
11/19
16:09
11/19/19
16:09
Initiation
Dana initiated  »

Dana initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

URBN

Urban Outfitters

$28.62

-1.54 (-5.11%)

16:08
11/19/19
11/19
16:08
11/19/19
16:08
Earnings
Urban Outfitters reports Q3 EPS 56c, consensus 57c »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

  • 05

    Dec

ALNY

Alnylam

$97.88

5.18 (5.59%)

16:08
11/19/19
11/19
16:08
11/19/19
16:08
Initiation
Alnylam initiated  »

Alnylam initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

  • 07

    Dec

  • 04

    Feb

DFFN

Diffusion Pharmaceuticals

$0.22

-0.0013 (-0.58%)

16:08
11/19/19
11/19
16:08
11/19/19
16:08
Hot Stocks
Diffusion Pharmaceuticals announces increased survival in TSC plus SOC trial »

Diffusion Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NEWM

New Media

$6.33

0.005 (0.08%)

, GCI

Gannett

$9.68

(0.00%)

16:06
11/19/19
11/19
16:06
11/19/19
16:06
Hot Stocks
New Media, Gannett complete merger »

New Media Investment…

NEWM

New Media

$6.33

0.005 (0.08%)

GCI

Gannett

$9.68

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AVYA

Avaya

$12.05

-0.28 (-2.27%)

16:06
11/19/19
11/19
16:06
11/19/19
16:06
Hot Stocks
Avaya names Anthony Bartolo chief product officer »

Avaya Holdings announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

NYMT

New York Mortgage

$6.25

0.01 (0.16%)

16:05
11/19/19
11/19
16:05
11/19/19
16:05
Syndicate
New York Mortgage files to sell 25M shares of common stock »

Morgan Stanley will serve…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IRTC

iRhythm

$71.03

1 (1.43%)

16:05
11/19/19
11/19
16:05
11/19/19
16:05
Hot Stocks
iRhythm receives Nasdaq deficiency notice due to delayed quarterly report »

iRhythm Technologies…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MSEX

Middlesex Water

$61.64

1.07 (1.77%)

16:04
11/19/19
11/19
16:04
11/19/19
16:04
Syndicate
Middlesex Water files to sell $35M in common stock »

Baird is acting as sole…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ORGO

Organogenesis

$8.00

0.01 (0.13%)

16:04
11/19/19
11/19
16:04
11/19/19
16:04
Syndicate
Organogenesis files to sell 9M shares of common stock »

Credit Suisse Securities…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CAPL

CrossAmerica

$17.35

0.225 (1.31%)

16:03
11/19/19
11/19
16:03
11/19/19
16:03
Hot Stocks
Couche-Tard sells interest in CrossAmerica to investment entities »

Alimentation Couche-Tard…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CKPT

Checkpoint Therapeutics

$1.53

-0.08 (-4.97%)

16:03
11/19/19
11/19
16:03
11/19/19
16:03
Syndicate
Checkpoint Therapeutics files to sell common stock, no amount given »

National Securities…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FBNC

First Bancorp

$38.66

0.39 (1.02%)

16:03
11/19/19
11/19
16:03
11/19/19
16:03
Hot Stocks
First Bancorp raises dividend 50%, announces $40M share repurchase program »

The Board of Directors of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AXNX

Axonics

$22.97

-0.48 (-2.05%)

16:01
11/19/19
11/19
16:01
11/19/19
16:01
Syndicate
Axonics files to sell $110M in common stock »

The offering is expected…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Nov

HD

Home Depot

$226.12

-12.86 (-5.38%)

16:00
11/19/19
11/19
16:00
11/19/19
16:00
Recommendations
Home Depot analyst commentary  »

Home Depot price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

  • 11

    Dec

CRC

California Resources

$6.39

-2.08 (-24.56%)

, BRY

Berry Petroleum

$8.89

-2.415 (-21.36%)

15:56
11/19/19
11/19
15:56
11/19/19
15:56
Periodicals
California Resources sees no significant impact from CA review, Bloomberg says »

California Resources…

CRC

California Resources

$6.39

-2.08 (-24.56%)

BRY

Berry Petroleum

$8.89

-2.415 (-21.36%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.